Healthcare PharmaceuticalsPrescription immunosuppressant medication (mycophenolate mofetil) for preventing organ rejection in transplant recipients, originally developed by Syntex Laboratories and now marketed by Roche.
immunosuppressiontransplantorgan-rejection